Literature DB >> 1332509

Oxygen radicals in cerebral ischemia.

C W Nelson1, E P Wei, J T Povlishock, H A Kontos, M A Moskowitz.   

Abstract

Superoxide production was measured as the superoxide dismutase (SOD)-inhibitable portion of nitro blue tetrazolium (NBT) reduction after cerebral ischemia-reperfusion in anesthetized cats equipped with cranial windows. Significant superoxide production was found in the early reperfusion period and continued for more than 1 h after ischemia. Superoxide was not detected in control animals not subjected to ischemia, during ischemia, and at 120 min of reperfusion. After ischemia, the vasoconstrictor response to arterial hypocapnia was reduced. This effect was prevented by pretreatment with SOD plus catalase or by deferoxamine. The response to topical acetylcholine was converted to vasoconstriction after ischemia. The normal vasodilator response reappeared spontaneously at 120 min of reperfusion. The vasodilator response to acetylcholine was preserved in animals pretreated with SOD plus catalase. Blood-brain barrier permeability to labeled albumin and horseradish peroxidase was increased after ischemia. These effects were minimized by pretreatment with SOD and catalase. We conclude that superoxide generation occurs during reperfusion after cerebral ischemia for a fairly long period and that superoxide and its derivatives are responsible at least in part for the vasodilation and the abnormal reactivity as well as for the increase in blood-brain barrier permeability to macromolecules seen after ischemia. Furthermore, the findings suggest that the agent responsible for the vascular abnormalities is hydroxyl radical generated via the iron-catalyzed Haber-Weiss reaction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1332509     DOI: 10.1152/ajpheart.1992.263.5.H1356

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  46 in total

1.  Polynitroxyl albumin and albumin therapy after pediatric asphyxial cardiac arrest: effects on cerebral blood flow and neurologic outcome.

Authors:  Mioara D Manole; Patrick M Kochanek; Lesley M Foley; T Kevin Hitchens; Hülya Bayır; Henry Alexander; Robert Garman; Li Ma; Carleton J C Hsia; Chien Ho; Robert S B Clark
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-30       Impact factor: 6.200

2.  The cyclooxygenase site, but not the peroxidase site of cyclooxygenase-2 is required for neurotoxicity in hypoxic and ischemic injury.

Authors:  Wenjin Li; Shasha Wu; Muzamil Ahmad; Jianfei Jiang; Hao Liu; Tetsuya Nagayama; Marie E Rose; Vladimir A Tyurin; Yulia Y Tyurina; Grigory G Borisenko; Natalia Belikova; Jun Chen; Valerian E Kagan; Steven H Graham
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

Review 3.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.

Authors:  Xiaoming Hu; T Michael De Silva; Jun Chen; Frank M Faraci
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

Review 4.  Cerebral vascular dysregulation in the ischemic brain.

Authors:  Alexander Kunz; Costantino Iadecola
Journal:  Handb Clin Neurol       Date:  2009

5.  Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury.

Authors:  Fang Hua; Jing Ma; Tuanzhu Ha; Jim Kelley; David L Williams; Race L Kao; John H Kalbfleisch; I William Browder; Chuanfu Li
Journal:  J Neuroimmunol       Date:  2008-06-27       Impact factor: 3.478

Review 6.  The physiology behind direct brain oxygen monitors and practical aspects of their use.

Authors:  Eileen Maloney-Wilensky; Peter Le Roux
Journal:  Childs Nerv Syst       Date:  2010-04       Impact factor: 1.475

Review 7.  Protecting against vascular disease in brain.

Authors:  Frank M Faraci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

8.  AM-36 modulates the neutrophil inflammatory response and reduces breakdown of the blood brain barrier after endothelin-1 induced focal brain ischaemia.

Authors:  R M Weston; B Jarrott; Y Ishizuka; J K Callaway
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

9.  Beta(2)-adrenoceptor agonist clenbuterol reduces infarct size and myocardial apoptosis after myocardial ischaemia/reperfusion in anaesthetized rats.

Authors:  Qiufang Zhang; Jizhou Xiang; Xuanbin Wang; Hui Liu; Benrong Hu; Mei Feng; Qin Fu
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

10.  Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia.

Authors:  Eduardo Candelario-Jalil; Armando González-Falcón; Michel García-Cabrera; Dalia Alvarez; Said Al-Dalain; Gregorio Martínez; Olga Sonia León; Joe E Springer
Journal:  J Neurochem       Date:  2003-08       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.